| Literature DB >> 26921941 |
Karim Dorgham1, Fabrice Cerini2, Hubert Gaertner2, Astrid Melotti2, Irène Rossitto-Borlat2, Guy Gorochov3, Oliver Hartley4.
Abstract
Phage display technology, which allows extremely rare ligands to be selected from libraries of variants according to user-defined selection criteria, has made a huge impact on the life sciences. In this chapter, we describe phage display methods for the discovery of chemokine analogs with enhanced pharmacological properties. We discuss strategies for chemokine library design and provide a recommended technique for library construction. We also describe cell-based library selection approaches that we have used to discover chemokine analogs, not only receptor antagonists but also variants with unusual effects on receptor signaling and trafficking. By providing a survey of the different phage chemokine projects that we have undertaken, we comment on the parameters most likely to affect success. Finally, we discuss how phage display-derived chemokine analogs with altered pharmacological activity represent valuable tools to better understand chemokine biology, and why certain among them have the potential to be developed as new medicines.Keywords: CCR5; CX3CR1; Chemokine; Phage display; Pharmacology
Mesh:
Substances:
Year: 2015 PMID: 26921941 DOI: 10.1016/bs.mie.2015.09.014
Source DB: PubMed Journal: Methods Enzymol ISSN: 0076-6879 Impact factor: 1.600